A Multicenter Randomized Double-Blind Placebo-controlled Dosing Safety and Efficacy Study of IMM 124-E (Hyperimmune Bovine Colostrum) for Patients with Severe Alcoholic Hepatitis
-
- STATUS
- Not Recruiting
Updated on 19 February 2024
Summary
The purpose of this study is to test the safety, tolerability, and effectiveness of Imm 124-E (Bovine Colostrum Drug Substance or BCDS) when used to treat severe alcoholic hepatitis.
Description
The purpose of this study is to test the safety, tolerability, and effectiveness of Imm 124-E (Bovine Colostrum Drug Substance or BCDS) when used to treat severe alcoholic hepatitis.
Details
| Condition | hepatitis |
|---|---|
| Age | 21years - 100years |
| Clinical Study Identifier | TX4419 |
| Last Modified on | 19 February 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.